Oncotarget cover image

Trending with Impact: Benign, Borderline, and Malignant Breast Tumors

Oncotarget

00:00

Distinguishing Benign and Malignant Breast Tumors Through Proteomic Markers

Exploration of the differences between FADs and benign PTs, highlighting potential prognostic markers and mechanisms driving the progression of PTs from borderline to malignant.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app